| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Matrix Proteins | 2 | 2023 | 144 | 1.570 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2019 | 66 | 1.230 |
Why?
|
| Lung | 8 | 2023 | 849 | 1.190 |
Why?
|
| Pericytes | 5 | 2022 | 81 | 1.110 |
Why?
|
| ADAM Proteins | 6 | 2015 | 53 | 0.880 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 35 | 0.800 |
Why?
|
| Membrane Proteins | 2 | 2023 | 617 | 0.650 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 20 | 0.640 |
Why?
|
| Matrix Metalloproteinase 7 | 6 | 2009 | 15 | 0.630 |
Why?
|
| Mice | 26 | 2023 | 8474 | 0.600 |
Why?
|
| Endothelial Cells | 3 | 2020 | 384 | 0.580 |
Why?
|
| Macrophages | 6 | 2020 | 647 | 0.520 |
Why?
|
| Inflammation | 8 | 2022 | 1030 | 0.470 |
Why?
|
| alpha-Defensins | 3 | 2009 | 3 | 0.440 |
Why?
|
| Gene Deletion | 2 | 2018 | 235 | 0.440 |
Why?
|
| Animals | 28 | 2023 | 20881 | 0.420 |
Why?
|
| ADAM17 Protein | 7 | 2018 | 28 | 0.410 |
Why?
|
| Heart Valves | 1 | 2013 | 171 | 0.380 |
Why?
|
| Pulmonary Fibrosis | 3 | 2022 | 157 | 0.350 |
Why?
|
| beta-Defensins | 1 | 2009 | 8 | 0.330 |
Why?
|
| Myofibroblasts | 2 | 2019 | 60 | 0.310 |
Why?
|
| Neutrophils | 3 | 2018 | 204 | 0.310 |
Why?
|
| Peritonitis | 5 | 2018 | 46 | 0.300 |
Why?
|
| Aging | 1 | 2013 | 911 | 0.280 |
Why?
|
| Collagen | 3 | 2023 | 636 | 0.280 |
Why?
|
| Integrin alpha Chains | 2 | 2018 | 9 | 0.270 |
Why?
|
| Intestinal Mucosa | 2 | 2015 | 219 | 0.220 |
Why?
|
| Extracellular Matrix | 3 | 2018 | 493 | 0.220 |
Why?
|
| ErbB Receptors | 3 | 2015 | 239 | 0.220 |
Why?
|
| Cell Line | 3 | 2021 | 1752 | 0.220 |
Why?
|
| Bleomycin | 2 | 2022 | 67 | 0.210 |
Why?
|
| Nitric Oxide | 2 | 2015 | 382 | 0.210 |
Why?
|
| Macrophages, Peritoneal | 2 | 2013 | 67 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 146 | 0.210 |
Why?
|
| Embryonic Development | 1 | 2023 | 100 | 0.210 |
Why?
|
| Endotoxins | 1 | 2022 | 76 | 0.200 |
Why?
|
| Tamoxifen | 1 | 2022 | 62 | 0.200 |
Why?
|
| Mice, Knockout | 9 | 2022 | 1692 | 0.200 |
Why?
|
| Lung Injury | 1 | 2022 | 38 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 12 | 2022 | 2791 | 0.200 |
Why?
|
| HIV Infections | 2 | 2020 | 791 | 0.190 |
Why?
|
| CD18 Antigens | 2 | 2011 | 9 | 0.180 |
Why?
|
| Microfilament Proteins | 3 | 2021 | 102 | 0.180 |
Why?
|
| Escherichia coli | 1 | 2022 | 368 | 0.180 |
Why?
|
| Cell Movement | 3 | 2011 | 630 | 0.180 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 163 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 245 | 0.170 |
Why?
|
| Weapons | 1 | 2019 | 2 | 0.170 |
Why?
|
| Thiourea | 1 | 2019 | 16 | 0.170 |
Why?
|
| Quinolines | 1 | 2019 | 48 | 0.160 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2018 | 26 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 195 | 0.160 |
Why?
|
| Protein Precursors | 3 | 2009 | 105 | 0.150 |
Why?
|
| Apoptosis | 3 | 2015 | 1641 | 0.150 |
Why?
|
| Trypsin Inhibitors | 1 | 2017 | 15 | 0.150 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2018 | 106 | 0.150 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2017 | 61 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 447 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2015 | 102 | 0.140 |
Why?
|
| Pulmonary Emphysema | 1 | 2017 | 71 | 0.140 |
Why?
|
| Fibrosis | 1 | 2018 | 371 | 0.140 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 2 | 2013 | 17 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 384 | 0.130 |
Why?
|
| Insulin Resistance | 2 | 2015 | 241 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1174 | 0.130 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2015 | 22 | 0.130 |
Why?
|
| Sepsis | 1 | 2018 | 233 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2022 | 117 | 0.130 |
Why?
|
| Cell Polarity | 1 | 2015 | 49 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 322 | 0.120 |
Why?
|
| Vasculitis | 1 | 2014 | 33 | 0.120 |
Why?
|
| Epithelial Cells | 2 | 2013 | 431 | 0.120 |
Why?
|
| Probiotics | 1 | 2013 | 14 | 0.110 |
Why?
|
| Signal Transduction | 4 | 2015 | 2689 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2018 | 902 | 0.110 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 3 | 0.110 |
Why?
|
| CD36 Antigens | 1 | 2013 | 9 | 0.110 |
Why?
|
| Osteopontin | 1 | 2013 | 28 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2013 | 38 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 199 | 0.110 |
Why?
|
| Receptor, TIE-2 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2014 | 202 | 0.110 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2013 | 65 | 0.110 |
Why?
|
| Integrases | 1 | 2013 | 31 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 371 | 0.110 |
Why?
|
| Aorta | 1 | 2014 | 316 | 0.110 |
Why?
|
| Versicans | 1 | 2013 | 44 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 626 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 226 | 0.110 |
Why?
|
| Systole | 1 | 2013 | 149 | 0.110 |
Why?
|
| Genes, ras | 1 | 2012 | 46 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 176 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 78 | 0.100 |
Why?
|
| Biomarkers | 1 | 2017 | 1593 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2012 | 46 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2011 | 9 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2013 | 396 | 0.100 |
Why?
|
| Cardiomegaly | 1 | 2013 | 213 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 175 | 0.100 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 206 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 245 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2011 | 71 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2013 | 714 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 177 | 0.090 |
Why?
|
| Male | 7 | 2018 | 37321 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2018 | 682 | 0.090 |
Why?
|
| Monocytes | 1 | 2011 | 210 | 0.090 |
Why?
|
| Electrocardiography | 1 | 2013 | 601 | 0.090 |
Why?
|
| Chemokines | 2 | 2008 | 119 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 2013 | 1083 | 0.090 |
Why?
|
| Enzyme Precursors | 1 | 2009 | 27 | 0.090 |
Why?
|
| Sulfates | 1 | 2009 | 28 | 0.090 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 1447 | 0.080 |
Why?
|
| Metalloendopeptidases | 1 | 2009 | 67 | 0.080 |
Why?
|
| Female | 6 | 2018 | 38074 | 0.080 |
Why?
|
| Humans | 12 | 2020 | 68618 | 0.080 |
Why?
|
| Glycosaminoglycans | 1 | 2009 | 88 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 332 | 0.080 |
Why?
|
| Catalysis | 1 | 2009 | 123 | 0.080 |
Why?
|
| Thioglycolates | 3 | 2013 | 5 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2008 | 99 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2009 | 107 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 160 | 0.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2009 | 133 | 0.080 |
Why?
|
| Vaccination | 1 | 2009 | 189 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 2550 | 0.070 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1076 | 0.070 |
Why?
|
| Genital Diseases, Female | 1 | 2006 | 23 | 0.070 |
Why?
|
| Chlamydia trachomatis | 1 | 2006 | 26 | 0.070 |
Why?
|
| Chlamydia Infections | 1 | 2006 | 41 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2018 | 2673 | 0.070 |
Why?
|
| Substrate Specificity | 3 | 2011 | 234 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2013 | 791 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 226 | 0.060 |
Why?
|
| Middle Aged | 2 | 2018 | 21147 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2004 | 156 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2014 | 149 | 0.050 |
Why?
|
| Aged | 1 | 2018 | 14862 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 223 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 244 | 0.050 |
Why?
|
| Chimera | 2 | 2013 | 33 | 0.050 |
Why?
|
| Hydroxyproline | 1 | 2022 | 33 | 0.050 |
Why?
|
| Paneth Cells | 1 | 2001 | 2 | 0.050 |
Why?
|
| Proteins | 2 | 2002 | 474 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 166 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2001 | 89 | 0.050 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 78 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 169 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1033 | 0.050 |
Why?
|
| Virus Latency | 1 | 2020 | 10 | 0.050 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2020 | 28 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2020 | 48 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 21403 | 0.050 |
Why?
|
| Phenotype | 2 | 2013 | 947 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 104 | 0.040 |
Why?
|
| Cytokines | 2 | 2015 | 866 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2021 | 237 | 0.040 |
Why?
|
| Pyroptosis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cecum | 1 | 2018 | 39 | 0.040 |
Why?
|
| Ligation | 1 | 2018 | 83 | 0.040 |
Why?
|
| Solubility | 1 | 2018 | 134 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2018 | 72 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 1851 | 0.040 |
Why?
|
| HIV | 1 | 2017 | 56 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2018 | 525 | 0.040 |
Why?
|
| Acute Disease | 1 | 2018 | 658 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 455 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 232 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 61 | 0.030 |
Why?
|
| Atrophy | 1 | 2015 | 112 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 86 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 597 | 0.030 |
Why?
|
| Kupffer Cells | 1 | 2015 | 75 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2015 | 75 | 0.030 |
Why?
|
| Asthma | 1 | 2019 | 345 | 0.030 |
Why?
|
| Triglycerides | 1 | 2015 | 184 | 0.030 |
Why?
|
| Palmitates | 1 | 2014 | 20 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 742 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 981 | 0.030 |
Why?
|
| Microvessels | 1 | 2014 | 43 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 81 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2013 | 30 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 1330 | 0.030 |
Why?
|
| Cattle | 1 | 2014 | 475 | 0.030 |
Why?
|
| Thymocytes | 1 | 2013 | 11 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 40 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1293 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 710 | 0.030 |
Why?
|
| Liposomes | 1 | 2013 | 107 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2013 | 150 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 217 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 282 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 420 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2011 | 8 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2002 | 231 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 498 | 0.030 |
Why?
|
| Fibrin | 1 | 2011 | 35 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 52 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2358 | 0.020 |
Why?
|
| L-Selectin | 1 | 2011 | 28 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 331 | 0.020 |
Why?
|
| Pancreas | 1 | 2012 | 225 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2011 | 48 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 235 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 901 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 324 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1118 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 50 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2009 | 7 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2009 | 20 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2009 | 17 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2008 | 21 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 114 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 120 | 0.020 |
Why?
|
| Heparin | 1 | 2009 | 205 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 99 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 115 | 0.020 |
Why?
|
| Peroxidase | 1 | 2008 | 40 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 337 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 284 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2009 | 132 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 397 | 0.020 |
Why?
|
| Colon | 1 | 2008 | 168 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 266 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 284 | 0.020 |
Why?
|
| Proteomics | 1 | 2008 | 246 | 0.020 |
Why?
|
| Colitis | 1 | 2008 | 156 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2006 | 25 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 455 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 122 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2006 | 79 | 0.020 |
Why?
|
| Vagina | 1 | 2006 | 88 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2006 | 90 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1664 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2077 | 0.010 |
Why?
|
| Disulfides | 1 | 2002 | 40 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 144 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 204 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 302 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 1038 | 0.010 |
Why?
|
| Defensins | 1 | 2001 | 3 | 0.010 |
Why?
|
| Leucine | 1 | 2001 | 41 | 0.010 |
Why?
|
| Valine | 1 | 2001 | 43 | 0.010 |
Why?
|
| Serine | 1 | 2001 | 99 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 272 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 251 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 357 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 1015 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 532 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 954 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 306 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1174 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 1027 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1745 | 0.010 |
Why?
|